| 144-80-9 |
| Sulphacetamide |
| Acetosulfamine |
| N-((4-Aminophenyl)sulfonyl)acetamide |
| N-Acetylsulfanilamide |
| N-Sulfanilylacetamide |
| Acetosulfamin |
| Albucid |
| Urosulfon |
| N-Sulphanilylacetamide |
| Sulfacetimide |
| Acetocid |
| Sulfacet |
| Sulfanilacetamide |
| Formosulfacetamide |
| Sulphasil |
| Urosulfone |
| Albamine |
| Alesten |
| Oclucid |
| Sulamyd |
| Sulfacyl |
| Region |
| Sulfanilazetamid |
| p-Aminobenzenesulfonacetamide |
| N-(4-aminophenyl)sulfonylacetamide |
| Sulfacetamidum |
| Sulphacetamidum |
| Steramide |
| Sebizon |
| Bleph-10 |
| N-Acetyl-4-aminobenzenesulfonamide |
| Sulf-10 |
| Ophthel-S |
| Sulfacetamida |
| p-Aminobenzenesulfonoacetamide |
| N'-Acetylsulfanilamide |
| Bleph-10 liquifilm |
| N-[(4-Aminophenyl)sulfonyl]acetamide |
| Isopto cetamide |
| Solfacetamide |
| OP-Sulfa 30 |
| Sulfacylum |
| Klaron |
| Acetamide, N-sulfanilyl- |
| N1-Acetylsulfanilamide |
| N-((p-Aminophenyl)sulfonyl)acetamide |
| N(sup1)-Acetylsulfanilamide |
| N-Acetylsulfanilamine |
| A-500 |
| Caswell No. 808A |
| N(sup 1)-Acetylsulfanilamide |
| N-(4-Aminobenzenesulfonyl)acetamide |
| Sulfacel-15 |
| Sulfanilamide, N(sup 1)-acetyl- |
| N-(4-Aminophenylsulfonyl)acetamide |
| Sulfacetamidum [INN-Latin] |
| N(sup 1)-Acetyl-4-aminophenylsulfonamide |
| SULSTER |
| Sulfacetamida [INN-Spanish] |
| N-[(p-Aminophenyl)sulfonyl]acetamide |
| NSC 63871 |
| CCRIS 6273 |
| N(1)-acetylsulfanilamide |
| Acetamide, N-((4-aminophenyl)sulfonyl)- |
| Acetamide, N-[(4-aminophenyl)sulfonyl]- |
| N-(p-Aminobenzenesulfonyl)acetamide |
| EINECS 205-640-6 |
| NSC-63871 |
| EPA Pesticide Chemical Code 077904 |
| BRN 0981718 |
| FML-S |
| DTXSID8026060 |
| UNII-4965G3J0F5 |
| CHEBI:63845 |
| AI3-26837 |
| MFCD00066501 |
| N(1)-acetyl-4-aminophenylsulfonamide |
| CHEMBL455 |
| 4965G3J0F5 |
| Triple sulfa (sulfacetamide) |
| MLS000069710 |
| DTXCID406060 |
| Sulfacetamide [USP:INN:BAN] |
| 4-14-00-02662 (Beilstein Handbook Reference) |
| N-acetyl-4-amino-benzenesulfonamide |
| TRYSUL COMPONENT SULFACETAMIDE |
| SULTRIN COMPONENT SULFACETAMIDE |
| VAGILIA COMPONENT SULFACETAMIDE |
| Sulfacyl (VAN) |
| GYNE-SULF COMPONENT SULFACETAMIDE |
| SULFACETAMIDE COMPONENT OF TRYSUL |
| NCGC00018242-04 |
| NCGC00018242-07 |
| SMR000058173 |
| SULFACETAMIDE COMPONENT OF SULTRIN |
| SULFACETAMIDE COMPONENT OF VAGILIA |
| SULFACETAMIDE COMPONENT OF GYNE-SULF |
| Solfacetamide [DCIT] |
| Sulfacetamide 100 microg/mL in Acetonitrile |
| Sulfacetamidum (INN-Latin) |
| Sulfanilazetamid [German] |
| Sulfacetamida (INN-Spanish) |
| SULFACETAMIDE (MART.) |
| SULFACETAMIDE [MART.] |
| Sulfacetamide (USP:INN:BAN) |
| SULFACETAMIDE (USP IMPURITY) |
| SULFACETAMIDE [USP IMPURITY] |
| CAS-144-80-9 |
| NSC63871 |
| SULFADIMIDINE IMPURITY E (EP IMPURITY) |
| SULFADIMIDINE IMPURITY E [EP IMPURITY] |
| Sulfacetamide (USP/INN) |
| Sulfacetamid |
| Sulfacetamide, 1 |
| N-[(4-Aminophenyl)sulfonyl]acetamide; Sulfacetamide; Sulfadimidine Imp. E (Pharmeuropa); Sulfadimidine Impurity E |
| CETAPRED |
| PREDAMIDE |
| Spectrum_000984 |
| Opera_ID_1990 |
| Prestwick0_000014 |
| Prestwick1_000014 |
| Prestwick2_000014 |
| Prestwick3_000014 |
| Spectrum2_001318 |
| Spectrum3_001017 |
| Spectrum4_001146 |
| Spectrum5_001230 |
| WLN: ZR DSWMV1 |
| SULFACETAMIDE [MI] |
| CBChromo1_000180 |
| Sulfanilamide, N1-acetyl- |
| 4-acetylaminosulfonylaniline |
| SULFACETAMIDE [INN] |
| NCIOpen2_002838 |
| Sulfacetamide, >=98.0% |
| Oprea1_686524 |
| Oprea1_810285 |
| SCHEMBL40863 |
| BSPBio_000047 |
| BSPBio_002773 |
| CBDivE_013934 |
| KBioGR_001691 |
| KBioSS_001464 |
| SULFACETAMIDE [VANDF] |
| MLS001076499 |
| DivK1c_000227 |
| SPECTRUM1500545 |
| SPBio_001415 |
| SPBio_001968 |
| SULFACETAMIDE [WHO-DD] |
| SULFACETAMIDE [WHO-IP] |
| BPBio1_000053 |
| GTPL12633 |
| HMS500L09 |
| KBio1_000227 |
| KBio2_001464 |
| KBio2_004032 |
| KBio2_006600 |
| KBio3_001993 |
| 4-[(acetylamino)sulfonyl]aniline |
| D10AF06 |
| S01AB04 |
| NINDS_000227 |
| 4-[(acetylamino) sulfonyl]aniline |
| HMS1921A11 |
| HMS2092I13 |
| HMS2232K07 |
| HMS3259G06 |
| HMS3374O02 |
| Pharmakon1600-01500545 |
| SULFACETAMIDE [ORANGE BOOK] |
| Sulfacetamide, >=98.0% (NT) |
| HY-N7123 |
| SULFACETAMIDE (TRIPLE SULFA) |
| Tox21_110846 |
| Tox21_201999 |
| Tox21_303100 |
| AC2473 |
| BDBM50316126 |
| CCG-39256 |
| NSC757323 |
| s5546 |
| 4-(ACETYLAMINOSULFONYL)ANILINE |
| SULFACETAMIDUM [WHO-IP LATIN] |
| AKOS000119729 |
| N-[(4-aminobenzene)sulfonyl]acetamide |
| Tox21_110846_1 |
| AC-7630 |
| DB00634 |
| KS-5327 |
| NC00538 |
| NSC-757323 |
| IDI1_000227 |
| NCGC00018242-01 |
| NCGC00018242-02 |
| NCGC00018242-03 |
| NCGC00018242-05 |
| NCGC00018242-06 |
| NCGC00018242-08 |
| NCGC00021857-03 |
| NCGC00021857-04 |
| NCGC00021857-05 |
| NCGC00257159-01 |
| NCGC00259548-01 |
| N-(P-AMINOPHENYLSULFONYL)ACETAMIDE |
| SY014752 |
| SBI-0051519.P003 |
| CS-0013812 |
| FT-0631838 |
| S0577 |
| EN300-18138 |
| D05947 |
| AB00052094_14 |
| N-ACETYL-4-AMINOBENZENESULFONIC ACID AMIDE |
| SR-01000000194 |
| Sulfacetamide, VETRANAL(TM), analytical standard |
| TRIPLE SULFA (SULFACETAMIDE) [ORANGE BOOK] |
| Q-201757 |
| Q2022983 |
| SR-01000000194-2 |
| Sulfacetamide, Antibiotic for Culture Media Use Only |
| BRD-K21520694-001-12-3 |
| N-((4-AMINOPHENYL)SULFONYL)ACETAMIDE [WHO-IP] |
| Z57202572 |
| Sulfacetamide, United States Pharmacopeia (USP) Reference Standard |
|
There are more than 10 synonyms. If you wish to see them all click here.
|